Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events. On March 4, 2026, AbbVie Inc. (“ AbbVie ”) completed its previously announced underwritten public offering (the “ Notes Offering ”) of $750,000,
. Financial Statements and Exhibits. (d) Exhibits . The following exhibits are provided as part of this Form 8-K: 4.1 Indenture, dated November 8, 2012, between